SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women ...Middle East

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN and ATLANTA, April 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in...

Hence then, the article about smart trial one year data demonstrates medtronic evolut tavr platform as optimal treatment for severe aortic stenosis in patients with small annulus which is primarily women was published today ( Sunday 07/04/2024 - 04:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women )

Also on site :

• 13-year-old rider dies following incident at northwest Indiana BMX park
• ‘I’m a Gastroenterologist—This Is the One Breakfast Mistake I’m Begging People To Stop Making'
• Minute Maid is Discontinuing Frozen Canned Juice, Once a Must-Have in Family Homes